MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

Search

Avita Therapeutics Inc

Geschlossen

3.37 3.69

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

3.2

Max

3.4

Schlüsselkennzahlen

By Trading Economics

Einkommen

-3.3M

-13M

Verkäufe

-1.4M

17M

Gewinnspanne

-77.289

Angestellte

260

EBITDA

-3.2M

-11M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+29.57% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

12. Feb. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-15M

106M

Vorheriger Eröffnungskurs

-0.32

Vorheriger Schlusskurs

3.37

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

Avita Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

9. Jan. 2026, 22:18 UTC

Market Talk

Changes Needed for Exxon Mobil to Return to Venezuela -- Market Talk

9. Jan. 2026, 21:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

9. Jan. 2026, 21:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Basic Materials Roundup: Market Talk

9. Jan. 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

9. Jan. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

9. Jan. 2026, 21:43 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

These Stocks Moved the Most Today: Oklo, Vistra, Opendoor, Intel, GM, Revolution Medicines, Tilray, and More -- Barrons.com

9. Jan. 2026, 20:39 UTC

Market Talk

GE Vernova Seen With Rising Concern of Overcapacity -- Market Talk

9. Jan. 2026, 20:38 UTC

Market Talk

U.S. Natural Gas Falls on Loose Supply Outlook -- Market Talk

9. Jan. 2026, 20:36 UTC

Akquisitionen, Fusionen, Übernahmen

Cathie Wood's ARK Invest Takes a New Stake in Broadcom -- and Sold Another Hot Stock -- Barrons.com

9. Jan. 2026, 20:30 UTC

Market Talk

Oil Makes Weekly Gains in Geopolitically Driven Trade -- Market Talk

9. Jan. 2026, 20:15 UTC

Market Talk

Chevron Seen With Modest Opportunity to Boost Venezuela Oil Production -- Market Talk

9. Jan. 2026, 20:07 UTC

Market Talk

Global Equities Roundup: Market Talk

9. Jan. 2026, 20:07 UTC

Market Talk

Goldman Sachs' Pivot from Consumer Lending Seen as Positive -- Market Talk

9. Jan. 2026, 19:58 UTC

Akquisitionen, Fusionen, Übernahmen

Merck in Talks to Buy Revolution Medicines for Around $30 Billion -- WSJ

9. Jan. 2026, 19:42 UTC

Market Talk

Adobe Seen With Weak Competitive Position Compared to Rivals -- Market Talk

9. Jan. 2026, 19:38 UTC

Akquisitionen, Fusionen, Übernahmen

Wolters Kluwer Acquires StandardFusion >WTKWY

9. Jan. 2026, 19:31 UTC

Ergebnisse

Qualcomm Stock Falls After Downgrade. The Apple Supplier Has an iPhone Problem. -- Barrons.com

9. Jan. 2026, 19:28 UTC

Ergebnisse

Apple Stock Set to Break Brutal Losing Streak. Why It Remains Evercore's 'Top Pick.' -- Barrons.com

9. Jan. 2026, 18:30 UTC

Market Talk

U.S. Oil Rig Count Falls by 3 to 409 -- Market Talk

9. Jan. 2026, 18:23 UTC

Market Talk

Reports of Canada Oil Sector's Demise Are Premature -- Market Talk

9. Jan. 2026, 17:20 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Basic Materials Roundup: Market Talk

9. Jan. 2026, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

9. Jan. 2026, 17:19 UTC

Market Talk

Energy Prices Not Seen Supporting More Drilling -- Market Talk

9. Jan. 2026, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

9. Jan. 2026, 17:07 UTC

Market Talk

McDonald's Promotions Appear Successful -- Market Talk

9. Jan. 2026, 17:06 UTC

Market Talk

Oil Futures on Track for Weekly Gains -- Market Talk

9. Jan. 2026, 17:05 UTC

Ergebnisse

Stocks Sail Past Jobs Data, Tariff Opinion Delay. Earnings Season Looms. -- Barrons.com

9. Jan. 2026, 16:57 UTC

Market Talk

Energy Activity Tumbles in 4Q, KC Fed Survey Finds -- Market Talk

9. Jan. 2026, 16:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9. Jan. 2026, 16:46 UTC

Market Talk

Dollar Could Stay Steady For Now, More Likely to Fall Than Rise -- Market Talk

Peer-Vergleich

Kursveränderung

Avita Therapeutics Inc Prognose

Kursziel

By TipRanks

29.57% Vorteil

12-Monats-Prognose

Durchschnitt 4.25 USD  29.57%

Hoch 5.5 USD

Tief 3 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Avita Therapeutics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

3 ratings

1

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

8.83 / 9.77Unterstützung & Widerstand

Kurzfristig

Very Strong Bearish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Weak Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.
help-icon Live chat